arel NY development i lp

520 madison avenue
18th floor
new york, new york 10022

NYS Entity Status
ACTIVE

NYS Filing Date
MARCH 21, 2014

NYS DOS ID#
4548673

County
NEW YORK

Jurisdiction
DELAWARE

Registered Agent
NONE

NYS Entity Type
FOREIGN LIMITED PARTNERSHIP

Name History
2014 - AREL NY DEVELOPMENT I LP









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • New Development: Soft in the Middle, Splashy Up Top
    By STEFANOS CHEN - Friday Sep 15, 2017

    The luxury market in New York is pulling in two directions, with developers betting on big-ticket palatial aeries and million-dollar “starter” homes.

    Source: NYT > Home Page
  • The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
    By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017

    Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”

    Source: NYT > Home Page
  • NY Times needs to come clean on wiretap headline
    By John Crudele - Thursday Sep 7, 2017

    The Justice Department announced this week that there was no evidence that Trump Tower was wiretapped, as President Trump alleged. OK, that almost settles the issue. I’m still waiting for the New York Times — the self-proclaimed “paper of record” — to explain its Jan. 20 front page story that had the headline “Wiretapped Data...

    Source: New York Post: Business
  • Two New York Detectives Are Charged With Raping Teenager in Custody
    By ALAN FEUER - Monday Oct 30, 2017

    The detectives were indicted on Monday on charges that they sexually assaulted an 18-year-old woman who was handcuffed inside a police van in Brooklyn.

    Source: NYT > Home Page
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • Restaurant Review: Lost in New York at Public Kitchen
    By PETE WELLS - Tuesday Oct 10, 2017

    At Jean-Georges Vongerichten’s new restaurant on the Lower East Side, the menu is supposed to be inspired by the whole city.

    Source: NYT > Home Page